webinar Validated bioassays for metabolic & gastrointestinal diseases: Accelerating development of GLP-1 & -2 therapeutics 20 December 2022 | By Eurofins DiscoverX Corp. In this webinar, we present an approach for building MOA-based, simple, ready-to-use GLP-1 and GLP-2 bioassays and discuss assay validation results from Eurofins BPT.
whitepaper Article: Understanding potency in cell and gene therapy development 12 December 2022 | By Bio-Rad Laboratories Read about the current state of the industry, challenges associated with potency assays and measuring product potency throughout the manufacturing process.
whitepaper Article: Challenges in developing CAR T-cell therapies 12 December 2022 | By Bio-Rad Laboratories Understand how quality control assays are being implemented in monitoring the development of CAR-T cells using high-throughput technologies in this article.
whitepaper Whitepaper: Correlate protein expression with genomic data and IHC 8 December 2022 | By Cell SIgnaling Technology Measure protein, DNA and RNA in FFPE tissue samples using rigorously IHC validated CST antibodies on the NanoString® nCounter® platform.
video Webinar: Making API candidate selection more productive 30 November 2022 | By Malvern Panalytical Discover everything pharmaceutical scientists need to know about solid form characterisation, starting with API selection.
video Video: Proteomics solutions for drug discovery 24 November 2022 | By Cell SIgnaling Technology Dr. Stokes, Associate Director Proteomics, discusses how proteomic studies can increase effectiveness, speed of target and biomarker identification.
video Webinar: Top tips for successful particle size analysis 21 November 2022 | By Malvern Panalytical Discover how Malvern Panalytical’s combination of analytical instrumentation and research services can take particle size analysis to the next level.
whitepaper Guide: Understanding an API and all its forms with XRPD 11 November 2022 | By Malvern Panalytical This Malvern Panalytical guide explores the use of Xray powder diffraction (XRPD) as a powerful tool to develop and improve pharmaceutical formulation.
whitepaper Whitepaper: Unique solutions for drug discovery and development 10 November 2022 | By Cell SIgnaling Technology Looking for solutions to resolve your unique challenges? We offer several customized products and services to move your discovery forward.
video Webinar: Plasmid platform facilitates transition to clinic 4 November 2022 | By Catalent Discover how a plasmid DNA manufacturing platform process is helpful from preclinical studies to scaling production for late-stage and commercial needs.
whitepaper Whitepaper: Cancer biomarkers for immunohistochemistry 3 November 2022 | By Cell SIgnaling Technology Streamline your cancer research using this guide that groups antibodies against critical cancer biomarkers according to biomarker type or tissue type.
news Simcere receives clearance to investigate a bi-functional fusion protein drug 28 October 2022 | By Ria Kakkad (Drug Target Review) The FDA has cleared the Simcere's investigational new drug application for SIM0237, an anti-PD-L1/IL-15 bi-functional fusion protein, for the treatment of adult patients with advanced solid tumours.
news FDA clears Cellenkos IND application for potential ALS treatment 20 October 2022 | By Victoria Rees (Drug Target Review) Following FDA clearance, Cellenkos will initiate Phase I and Phase Ib trials of CK0803, allogeneic regulatory T cells, in patients with ALS.
whitepaper ebook: Current and emerging strategies for engineered cell therapies: cancer immunotherapy 19 October 2022 | By Takara Bio This exclusive ebook takes an in-depth look at recent developments in the field of cancer immunotherapy, with expert interviews exploring how researchers are advancing next-generation cell therapies into the clinic.
whitepaper Application note: Afucosylated mAb expression & antibody efficacy 17 October 2022 | By Sino Biological Inc. Sino Biological’s “FucoFree” eukaryotic expression system provides high-yield and high-throughput afucosylated monoclonal antibody (mAb) production.
